Department of Public Health & Maternal and Child Health, Faculty of Medicine, Universidad Complutense de Madrid, Madrid, 28040, Spain.
Preventive Medicine and Public Health Teaching and Research Unit. Health Sciences Faculty, Rey Juan Carlos University, Alcorcón, Madrid, Spain.
Cardiovasc Diabetol. 2023 Sep 29;22(1):266. doi: 10.1186/s12933-023-01995-1.
The impact of Type 2 Diabetes (T2D) on the outcomes of heart transplantation (HT) has not yet been clearly established. The objectives of this study were to examine the trends in the prevalence of T2D among individuals who underwent a HT in Spain from 2002 to 2021, and to compare the clinical characteristics and hospitalization outcomes between HT recipients with and without T2D.
We used the national hospital discharge database to select HT recipients aged 35 and older. The International Classification of Diseases, Ninth and Tenth Revisions (ICD-9 and ICD-10) were used to identify patients with and without T2D. We also recorded comorbidities, complications of HT, and procedures. Propensity score matching (PSM) and Cox regression were used to analyze the effect of T2D on in-hospital mortality (IHM).
Between 2002 and 2021, a total of 4429 HTs (T2D, 19.14%) were performed in Spain. The number of HTs in patients with T2D decreased from 2002 to 2005 (n = 171) to 2014-2017 (n = 154), then rose during 2018-2021 (n = 186). Complications of HT increased in patients with and without T2D over the study period (26.9% and 31.31% in 2002-2005 vs. 42.47% and 45.01% in 2018-2021, respectively). The results of the PSM showed that pneumonia and Gram-negative bacterial infections were less frequent in patients with T2D and that these patients less frequently required hemodialysis, extracorporeal membrane oxygenation (ECMO), and tracheostomy. They also had a shorter hospital stay and lower IHM than patients without diabetes. The variables associated with IHM in patients with T2D were hemodialysis and ECMO. IHM decreased over time in people with and without T2D. The Cox regression analysis showed that T2D was associated with lower IHM (HR 0.77; 95% CI 0.63-0.98).
The number of HTs increased in the period 2018-2021 compared with 2002-2005 in patients with and without T2D. Over time, complications of HT increased in both groups studied, whereas IHM decreased. The presence of T2D is associated with lower IHM.
2 型糖尿病(T2D)对心脏移植(HT)结局的影响尚未明确。本研究的目的是检验 2002 年至 2021 年期间西班牙接受 HT 的患者中 T2D 患病率的变化趋势,并比较 T2D 阳性和 T2D 阴性 HT 受者的临床特征和住院结局。
我们使用国家医院出院数据库选择年龄 35 岁及以上的 HT 受者。使用国际疾病分类,第九和第十修订版(ICD-9 和 ICD-10)来识别有和没有 T2D 的患者。我们还记录了合并症、HT 并发症和操作。采用倾向评分匹配(PSM)和 Cox 回归分析 T2D 对住院死亡率(IHM)的影响。
2002 年至 2021 年间,西班牙共进行了 4429 例 HT(T2D,19.14%)。T2D 患者的 HT 数量从 2002 年至 2005 年(n=171)减少到 2014-2017 年(n=154),然后在 2018-2021 年期间上升。在研究期间,有和没有 T2D 的 HT 患者的并发症都有所增加(2002-2005 年为 26.9%和 31.31%,2018-2021 年分别为 42.47%和 45.01%)。PSM 的结果表明,T2D 患者的肺炎和革兰氏阴性菌感染较少,这些患者较少需要血液透析、体外膜氧合(ECMO)和气管切开术。他们的住院时间也较短,IHM 低于无糖尿病患者。与 T2D 相关的 IHM 相关变量是血液透析和 ECMO。有和没有 T2D 的患者的 IHM 随时间下降。Cox 回归分析表明,T2D 与较低的 IHM 相关(HR 0.77;95%CI 0.63-0.98)。
与 2002-2005 年相比,2018-2021 年 T2D 阳性和 T2D 阴性患者的 HT 数量均有所增加。随着时间的推移,两组患者的 HT 并发症均有所增加,而 IHM 则有所下降。T2D 与较低的 IHM 相关。